Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

Description

The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease. The main questions it aims to answer are:

* Is this product safe to deliver to humans
* Is the conduct of this trial feasible

Participants will be asked to:

* Agree to testing and monitoring before and after product administration
* Receive investigational product
* Agree to lifelong follow-up Researchers will compare subjects from the same pool to see if there is a difference between treated and untreated subjects.